Human H7N9 virus induces a more pronounced pro-inflammatory cytokine but an attenuated interferon response in human bronchial epithelial cells when compared with an epidemiologically-linked chicken H7N9 virus

Virology Journal

Volumn 13, Issue 1, 2016, Pages

  To, Kelvin K W ^a,b   Lau, Candy C Y ^a   Woo, Patrick C Y ^a,b   Lau, Susanna K P ^a,b   Chan, Jasper F W ^a,b   Chan, Kwok Hung ^a,b   Zhang, Anna J X ^a,b   Chen, Honglin ^a,b,c   Yuen, Kwok Yung ^a,b,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Avian influenza virus; Chemokine; Chicken; Cytokine; H7N9; Human; IL 8; Interferon; Interferon lambda 1; Viral load

Indexed keywords

BETA INTERFERON; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 29; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID; INTERFERON;

ADULT; ARTICLE; BRONCHIAL EPITHELIAL CELL; BRONCHUS EPITHELIUM; CALU 3 CELL LINE; CELL LINE; CELL LYSATE; CHICKEN; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); MALE; MIDDLE AGED; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS LOAD; ANIMAL; AVIAN INFLUENZA; INFLUENZA; METABOLISM; PHYSIOLOGY; RESPIRATORY MUCOSA; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CELL LINE; CHICKENS; CYTOKINES; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; INTERFERONS; RESPIRATORY MUCOSA; VIRAL LOAD; VIRUS REPLICATION;

EID: 85007609839     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0498-2     Document Type: Article

References (49)

1. To KK, Chan JF, Chen H, Li L, Yuen KY. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: A tale of two cities. Lancet Infect Dis. 2013; 13: 809-21.
2. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, Yao H, Wo J, Fang Q, Cui D, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013; 381: 1916-25.
3. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013; 368: 1888-97.
4. To KK, Song W, Lau SY, Que TL, Lung DC, Hung IF, Chen H, Yuen KY. Unique reassortant of influenza A(H7N9) virus associated with severe disease emerging in Hong Kong. J Infect. 2014; 69: 60-8.
5. Marjuki H, Mishin VP, Chesnokov AP, Jones J, De La Cruz JA, Sleeman K, Tamura D, Nguyen HT, Wu HS, Chang FY, et al. Characterization of drugresistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015; 211: 249-57.
6. William T, Thevarajah B, Lee SF, Suleiman M, Jeffree MS, Menon J, Saat Z, Thayan R, Tambyah PA, Yeo TW et al. Avian influenza (H7N9) virus infection in Chinese tourist in Malaysia, 2014. Emerg Infect Dis. 2015; 21: 142-5.
7. World Health Organization: Human infection with avian influenza A(H7N9) virus-Canada. Available at http://www. who. int/csr/don/01-february-2015-avian-influenza/en/. Accessed on December 10, 2015.
8. Centre for Health Protection: Avian Influenza Report. Reporting period: December 6, 2015-December 12, 2015 (Week 50). 2015.
9. World Health Organization: Influenza at the human-animal interface. Summary and assessment as of 14 December 2015. Available at http://www. who. int/influenza/human-animal-interface/Influenza-Summary-IRA- HA-interface-14-Dec-2015. pdf?ua=1. Accessed on December 23, 2015.
10. Cheng VC, To KK, Tse H, Hung IF, Yuen KY. Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev. 2012; 25: 223-63.
11. To KK, Ng KH, Que TL, Chan JM, Tsang KY, Tsang AK, Chen H, Yuen K. Avian influenza A H5N1 virus: A continuous threat to humans. Emerg Microbes Infect. 2012; 1, e25.
12. To KK, Chan JF, Yuen KY. Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9). Curr Opin Pulm Med. 2014; 20: 225-32.
13. Wang C, Yu H, Horby PW, Cao B, Wu P, Yang S, Gao H, Li H, Tsang TK, Liao Q, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis. 2014; 58: 1095-103.
14. Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014; 14: 57-69.
15. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, To KK, Chen H, Yang Y, Liang W et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis. 2013; 57: 1449-57.
16. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010; 50: 850-9.
17. Guo J, Huang F, Liu J, Chen Y, Wang W, Cao B, Zou Z, Liu S, Pan J, Bao C, et al. The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes. Sci Rep. 2015; 5: 10942.
18. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, Ren Y, Wang J, Dong Y, Bao M, et al. Early hypercytokinemia is associated with interferoninduced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A. 2014; 111: 769-74.
19. Guo L, Zhang X, Ren L, Yu X, Chen L, Zhou H, Gao X, Teng Z, Li J, Hu J, et al. Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerg Infect Dis. 2014; 20: 192-200.
20. Lee AC, Zhu H, Zhang AJ, Li C, Wang P, Li C, Chen H, Hung IF, To KK, Yuen KY. Suboptimal Humoral Immune Response against Influenza A(H7N9) Virus Is Related to Its Internal Genes. Clin Vaccine Immunol. 2015; 22: 1235-43.
21. Wu D, Zou S, Bai T, Li J, Zhao X, Yang L, Liu H, Li X, Yang X, Xin L, et al. Poultry farms as a source of avian influenza A (H7N9) virus reassortment and human infection. Sci Rep. 2015; 5: 7630.
22. Cui L, Liu D, Shi W, Pan J, Qi X, Li X, Guo X, Zhou M, Li W, Li J, et al. Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus. Nat Commun. 2014; 5: 3142.
23. Yang S, Chen Y, Cui D, Yao H, Lou J, Huo Z, Xie G, Yu F, Zheng S, Yang Y et al. Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: A serological study. J Infect Dis. 2014; 209: 265-9.
24. Li C, Li C, Zhang AJ, To KK, Lee AC, Zhu H, Wu HW, Chan JF, Chen H, Hung IF, et al. Avian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitor. PLoS ONE. 2014; 9: e107966.
25. Woo PC, Tung ET, Chan KH, Lau CC, Lau SK, Yuen KY. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis. 2010; 201: 346-53.
26. Li IW, Chan KH, To KW, Wong SS, Ho PL, Lau SK, Woo PC, Tsoi HW, Chan JF, Cheng VC, et al. Differential susceptibility of different cell lines to swineorigin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol. 2009; 46: 325-30.
27. Zhang AJ, To KK, Li C, Lau CC, Poon VK, Chan CC, Zheng BJ, Hung IF, Lam KS, Xu A, Yuen KY. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity. J Infect Dis. 2013; 207: 1270-80.
28. Chan JF, Chan KH, Choi GK, To KK, Tse H, Cai JP, Yeung ML, Cheng VC, Chen H, Che XY, et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis. 2013; 207: 1743-52.
29. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006; 12: 1203-7.
30. Chan JF, To KK, Tse H, Lau CC, Li IW, Hung IF, Chan KH, Cheng VC, Lai TS, Woo PC, et al. The lower serum immunoglobulin G2 level in severe cases than in mild cases of pandemic H1N1 2009 influenza is associated with cytokine dysregulation. Clin Vaccine Immunol. 2011; 18: 305-10.
31. Zeng H, Belser JA, Goldsmith CS, Gustin KM, Veguilla V, Katz JM, Tumpey TM: A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus. J Virol. 2015; 89: 4655-67.
32. Chan MC, Chan RW, Chan LL, Mok CK, Hui KP, Fong JH, Tao KP, Poon LL, Nicholls JM, Guan Y, Peiris JS: Tropism and innate host responses of a novel avian influenza A H7N9 virus: An analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respir Med. 2013; 1: 534-42.
33. Morrison J, Josset L, Tchitchek N, Chang J, Belser JA, Swayne DE, Pantin-Jackwood MJ, Tumpey TM, Katze MG: H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice. J Virol. 2014; 88: 10556-68.
34. Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. MBio. 2014; 5: e01102-13.
35. Zhang Q, Shi J, Deng G, Guo J, Zeng X, He X, Kong H, Gu C, Li X, Liu J, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science. 2013; 341: 410-4.
36. Davis AS, Chertow DS, Moyer JE, Suzich J, Sandouk A, Dorward DW, Logun C, Shelhamer JH, Taubenberger JK: Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea. J Histochem Cytochem. 2015; 63: 312-28.
37. Pearce MB, Jayaraman A, Pappas C, Belser JA, Zeng H, Gustin KM, Maines TR, Sun X, Raman R, Cox NJ, et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A. 2012; 109: 3944-9.
38. Aevermann BD, Pickett BE, Kumar S, Klem EB, Agnihothram S, Askovich PS, Bankhead A, 3rd, Bolles M, Carter V, Chang J, et al. A comprehensive collection of systems biology data characterizing the host response to viral infection. Sci Data. 2014; 1: 140033.
39. Lau SK, Lau CC, Chan KH, Li CP, Chen H, Jin DY, Chan JF, Woo PC, Yuen KY: Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013; 94: 2679-90.
40. McDermott JE, Shankaran H, Eisfeld AJ, Belisle SE, Neuman G, Li C, McWeeney S, Sabourin C, Kawaoka Y, Katze MG, Waters KM: Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems. BMC Syst Biol. 2011; 5: 190.
41. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, Nicholls JM, Zhu H, Guan Y, Peiris JM: Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio. 2013; 4.
42. Chi Y, Zhu Y, Wen T, Cui L, Ge Y, Jiao Y, Wu T, Ge A, Ji H, Xu K, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis. 2013; 208: 1962-7.
43. Allen TC, Kurdowska A. Interleukin 8 and acute lung injury. Arch Pathol Lab Med. 2014; 138: 266-9.
44. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk CJ, Hartshorn KL, Mason RJ: Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol. 2009; 182: 1296-304.
45. Sutejo R, Yeo DS, Myaing MZ, Hui C, Xia J, Ko D, Cheung PC, Tan BH, Sugrue RJ: Activation of type I and III interferon signalling pathways occurs in lung epithelial cells infected with low pathogenic avian influenza viruses. PLoS ONE. 2012; 7: e33732.
46. Narasaraju T, Ng HH, Phoon MC, Chow VT. MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol. 2010; 42: 732-43.
47. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, Murakami S, Yamayoshi S, Iwatsuki-Horimoto K, Sakoda Y, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013; 501: 551-5.
48. Knepper J, Schierhorn KL, Becher A, Budt M, Tonnies M, Bauer TT, Schneider P, Neudecker J, Ruckert JC, Gruber AD, et al. The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. MBio. 2013; 4: e00601-13.
49. Zhao C, Qi X, Ding M, Sun X, Zhou Z, Zhang S, Zen K, Li X: Proinflammatory cytokine dysregulation is associated with novel avian influenza A (H7N9) virus in primary human macrophages. J Gen Virol. 2015.